$2.61
0.020.77%
At close: -
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
Sector
Healthcare
Region
US
AUM
43.69M
Fund Score
AdvisorShares Pure Cannabis ETF (ARCA:YOLO) Quotes, Forecast and News Summary
AdvisorShares Pure Cannabis ETF (ARCA: YOLO) stock price, news, charts, stock research, profile.
| Open | $2.58 |
| High | $2.64 |
| 52 Wk High | $4.76 |
| AUM | 43.69M |
| Dividend | $0.06 |
| Ex-Div Date | Jun 24, 2024 |
| Volume | 84.59K |
| Market Cap | $1.28B |
| Mgmt Fee | 0.31% |
| P/E Ratio | 11.12 |
| Prev. Close | $2.59 |
| Low | $2.57 |
| 52 Wk Low | $2.45 |
| Shares Out | 12.84M |
| Yield | 1.77% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 48.25K |
| Beta | 1.52 |
| Avg. Expense Ratio | NA% |
| P/B Ratio | 0.95 |
Recent News
FAQ
Q
How do I buy AdvisorShares Pure Cannabis ETF (YOLO) stock?
A
You can purchase shares of AdvisorShares Pure Cannabis ETF (ARCA:YOLO) through any online brokerage.
Q
Who are AdvisorShares Pure Cannabis ETF (YOLO) competitors?
A
There are no as such competitors for AdvisorShares Pure Cannabis ETF.
Q
What is the forecast, or price target, for AdvisorShares Pure Cannabis ETF (YOLO) stock?
A
There is no analysis for AdvisorShares Pure Cannabis ETF to provide a consensus price target.
Q
What is the current price for AdvisorShares Pure Cannabis ETF (YOLO)?
A
The stock price for AdvisorShares Pure Cannabis ETF (ARCA: YOLO) is $2.61 last updated November 22, 2024 at 8:00 PM EST.
Q
Does AdvisorShares Pure Cannabis ETF (YOLO) pay a dividend?
A
A quarterly cash dividend of 0.04 per share of Class A Common Stock. The quarterly cash dividend was payable on September 30, 2024 to stockholders of record on September 23, 2024.
Q
When is AdvisorShares Pure Cannabis ETF (ARCA:YOLO) reporting earnings?
A
AdvisorShares Pure Cannabis ETF does not have any upcoming earnings scheduled.
Q
Is AdvisorShares Pure Cannabis ETF (YOLO) going to split?
A
There is no upcoming split for AdvisorShares Pure Cannabis ETF.
| Open | $2.58 |
| High | $2.64 |
| 52 Wk High | $4.76 |
| AUM | 43.69M |
| Dividend | $0.06 |
| Ex-Div Date | Jun 24, 2024 |
| Volume | 84.59K |
| Market Cap | $1.28B |
| Mgmt Fee | 0.31% |
| P/E Ratio | 11.12 |
| Prev. Close | $2.59 |
| Low | $2.57 |
| 52 Wk Low | $2.45 |
| Shares Out | 12.84M |
| Yield | 1.77% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 48.25K |
| Beta | 1.52 |
| Avg. Expense Ratio | NA% |
| P/B Ratio | 0.95 |
ETF Details
| Sector | Healthcare |
| Category | Low Performer-Low Growth |
| Investment Style | Small Cap Growth |
| Fund Inception | Apr 17, 2019 |
| Managers | Dan S. Ahrens |
| Definition | Companies with inferior financial performance and low growth potential dominate this Equity Fund's portfolio |
Investment Policy
The fund is an actively managed exchange-traded fund (ETF) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business and in derivatives or other instruments that have economic characteristics similar to such securities. It is non-diversified.
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2024 Benzinga | All Rights Reserved